The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration.

Although not meant to be used as a primary screening tool, the technology further evaluates skin lesions that doctors have already flagged as suspicious, the FDA noted in an agency news release.  

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=ZGI0ZDdhMzUtNmUwMC00NzQwLTk5MmItZmQwZTgwOTRjMTYz&client=Nw%3D%3D&section=undefined